Asthma Warnings Not Working Well, FDA Fears As GSK Seeks Expanded LABA Approval
LABA prescribing patterns haven’t changed despite FDA’s labeling instructions on asthma safety concerns, agency concludes.
LABA prescribing patterns haven’t changed despite FDA’s labeling instructions on asthma safety concerns, agency concludes.